Book a demo

Super-Resolution Microscopy Patents: Who Leads, Where Gaps Are 2026

Super-Resolution Microscopy Patents: Who Leads, Where Gaps Are 2026
https://www.patsnap.com/resources/blog/rd-blog/super-resolution-microscopy-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Optical Microscopy
Super-Resolution Microscopy Patents: Mapping the Leaders and the Open Ground
  • Filing concentrated but not locked up. the top five assignees hold 27.5% of all 1,307 records in scope, and the top ten hold 38.8% — leaving a long tail of single- and few-filing entrants.
  • Growth has cooled from its 2020 peak. filings ran 90 in 2017 and peaked at 120 in 2020; from 2021 (119) to 2024 (87), the last fully-published year, volume fell 27%.
  • Imaging claims outnumber optics claims. G01N (material analysis & testing) touches 57.2% of records versus 31.5% for G02B (optical elements & systems), meaning the analytical and diagnostic layer is where the claim density actually sits.
Get a prior-art report on your approach
1,307
Published Records
28%
Top-5 Share of All Records
-27%
Filing Growth 2021→2024
US
Leading Jurisdiction

Filing growth compares 2021 (119 records) with 2024 (87) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 1,307 records in scope (CR5), not by the ranked leaders only.

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What the filing record shows

Super-resolution microscopy patenting spans optical hardware, image reconstruction and the diagnostic assays built on top of localization data. The search captures 1,307 patent families published between 2015 and mid-2026, drawing on techniques including single-molecule localization and stimulated emission depletion, combined with the practical bottlenecks that determine whether a method works outside a lab bench: localization precision, photoswitching buffers, drift correction, labelling density and phototoxicity. That combination of core technique and applied constraint is deliberate — it is where the commercially relevant claims tend to sit, rather than in the underlying optical principle alone.

Filing activity rose through the late 2010s, peaked in 2020, and has since eased off from that high, though the most recent years are still filling in as publications lag filing by roughly eighteen months. The assignee base includes a mix of academic institutions, instrument makers and diagnostics companies, with a small number of entities accounting for a disproportionate share of the record — a pattern worth checking before committing to a filing strategy in any single sub-area.

Filing volume and technology composition, 2015-2026
  1. 1PRESIDENT & FELLOWS OF HARVARD COLLEGE152
  2. 2LABRADOR DIAGNOSTICS LLC82
  3. 3BIOAXIAL45
  4. 4ELEMENT BIOSCIENCES INC41
  5. 5ABBERIOR INSTR GMBH40
  6. 6XGENOMES CORP34
  7. 7MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV32
  8. 8THE RGT UNIV OF MICHIGAN31
  9. 9CALIFORNIA INST OF TECH26
  10. 10THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK24
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Super-Resolution Microscopy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The Data

Filing trends and technology composition

Two views of the same 1,307-record dataset: how filing volume has moved year over year, and how those records distribute across IPC subclasses.

Filing trend, 2017-2026

Filings climbed from 90 in 2017 to a peak of 120 in 2020, then eased to 87 by 2024 — a 27% decline over the 2021-2024 span. 2025 and 2026 figures are understated because publication typically lags filing by around 18 months.

Filing trend, 2017-202603060901209020172018201912020202021202220232024202512026Most recent year is partial — publication lag means later filings are not yet visible.

Technology composition by IPC subclass

G01N (material analysis & testing) appears in 57.2% of the 1,307 records, ahead of G02B (optical elements & systems) at 31.5% and C12Q (enzyme/DNA-related measuring) at 27.5%. Because records can carry multiple IPC codes, these shares sum to well over 100% and should be read individually against the full record total, not against each other.

Technology composition by IPC subclassG01N · Material analysis & testing74757.2%G02B · Optical elements & systems41231.5%C12Q · Measuring & testing involving …35927.5%G06T · Image data processing & genera…1229.3%C12N · Microorganisms & genetic engin…846.4%G16B · Bioinformatics826.3%A61K · Medicinal preparations715.4%B01L · Lab apparatus695.3%Other80361.4%

Shares are the percentage of the 1,307 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Super-Resolution Microscopy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Super-Resolution Microscopy with Eureka

This page is one run against one query. Ask Eureka your own question about super-resolution microscopy and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

Representative and most-cited filings

Representative Filing
US11676247B22023-06-13

US11676247B2 — Reconstruction of dense super-resolution images from single molecule localization microscopy

INSTITUT PASTEUR

The patent covers reconstructing a synthetic dense super-resolution image from a sequence of diffraction-limited images acquired by single molecule localization microscopy. A sparse localization image is first reconstructed using standard SMLM processing, then fed — alone or alongside a low-resolution wide-field image — into an artificial neural network that outputs the synthetic dense image.Filed by Institut Pasteur; published 2023-06-13.

US11676247B2 — patent drawing 1US11676247B2 — patent drawing 2
View full record
Most-cited records in this dataset
#Publication no.Patent titleCitations
1US20070057211A1Multifocal imaging systems and method338
2US20160327779A1Systems And Methods for Three Dimensional Imaging329
3US8435738B2Systems and methods for multi-analysis312
4US20170220733A1Systems and methods for determining nucleic acids296
5US20050244863A1Molecular arrays and single molecule detection270
6US20140234949A1Systems and methods for fluid and component handling263
7US20130078624A1Systems and methods for multi-purpose analysis263
8US20140296089A1Systems and methods for multi-analysis256
9US20190333199A1Systems and methods for deep learning microscopy254
10WO2013052318A1Systems and methods for multi-analysis249

Citation counts reflect accumulated influence within the searched corpus and favour older filings; treat them as a signal of historical impact rather than current commercial weight.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Super-Resolution Microscopy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis

 
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the numbers mean for a filing decision

Three patterns stand out once volume, concentration and claim topic are read together.

Concentration
27.5% / 38.8%
top 5 / top 10 share of 1,307 records

The top of the field is dense, the rest is open

The five most active assignees account for 27.5% of all records and the top ten for 38.8%. That leaves roughly six in ten records spread across the other ranked assignees and unranked filers, which is a wide base for a new entrant to find adjacent, unblocked claim territory rather than competing head-on with the leaders.

Based on the full 100-assignee ranking.
Momentum
-27%
filing change, 2021 to 2024

Volume has pulled back from its 2020 peak

Filings rose steadily to 120 in 2020 before easing to 87 by 2024, a 27% decline over that three-year window. This reads as a maturing claim space rather than a collapsing one — the foundational optical and reconstruction techniques are largely staked out, and later filings increasingly target specific assay or diagnostic applications.

2025-2026 figures will rise as publication catches up.
Claim topic
57.2%
of records touch G01N

The analytical layer, not just the optics, is where claims concentrate

G01N (material analysis & testing) appears in more than half of all records, well ahead of G02B optical systems at 31.5% and C12Q enzyme/DNA measurement at 27.5%. Filers are patenting what the microscopy enables — assays, diagnostics, molecular detection — at least as heavily as the imaging hardware itself.

Shares sum above 100% because records carry multiple IPC codes.
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to super-resolution microscopy, with the prior art for and against each one.

Find the white space →
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Super-Resolution Microscopy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who is filing, and where the activity has cooled

The ranking spans 100 assignees drawn from academia, instrument makers and diagnostics firms. Recent-year momentum data shows several previously active filers dropping to zero in the latest tracked year — a pattern consistent with the broader post-2020 pullback rather than any single company's retreat.

Leader
152
records

A single assignee well ahead of the field

The top-ranked assignee holds 152 records, notably ahead of the fifth-place holder at 40 and tenth place at 24 — a steep drop-off after the leader rather than a gradual taper.

Ranking counted in patent families.
Mid-field
40 / 24
records, 5th / 10th place

A quick fall-off after the leader

Fifth place holds 40 records and tenth place 24, meaning the gap between the leader and the rest of the top ten is far larger than the gaps within the top ten itself.

Compare against the 1,307-record total.
Collaboration
10 pairs
co-assignee pairs identified

Co-filing is limited and clustered

Only ten co-assignee pairs appear in the dataset, and the strongest links sit within related corporate or institutional families rather than across unrelated organisations — collaborative filing is the exception here, not the norm.

Strongest pairs share 8-11 joint records.
🔍
Under-claimed branches worth checking before filing
These sit adjacent to the dense G01N/G02B core but carry noticeably lighter claim density in this dataset.
Drift correction algorithms for live-cell SMLMPhotoswitching buffer chemistryLabelling density optimisation for dense samplesPhototoxicity mitigation in live imagingBioinformatics pipelines for localization data (G16B)
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
Abberior Instruments GmbH1
President & Fellows of Harvard College0-100%
Theranos, Inc.0
BioAxial SAS0-100%
Element Biosciences, Inc.0-100%
Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V.0-100%
xGenomes Corp0
The Regents of the University of Michigan0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Super-Resolution Microscopy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's Next

Turning this landscape into a filing or freedom-to-operate position

The dataset points to where claim density sits and where it thins out. Turning that into a decision — file, design around, or license — takes a closer read of the specific claims involved.

Check freedom-to-operate against the leader's portfolio

With 152 records versus 40 at fifth place, the top assignee's claim scope deserves a direct check before committing engineering resources to overlapping approaches.

Run a freedom-to-operate check in Eureka

Explore the under-claimed branches directly

Drift correction, photoswitching chemistry and labelling density optimisation show up across the dataset but without a dominant assignee — a reasonable place to look for open claim territory.

Explore white space in Eureka

Track momentum, not just headcount

Several previously active filers show zero activity in the latest tracked year; distinguishing a genuine pullback from a publication-lag artefact matters for competitive monitoring.

Set up assignee tracking in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Super-Resolution Microscopy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about super-resolution microscopy patents

Answers are grounded in the same dataset. Derived from a Patsnap search on Super-Resolution Microscopy covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Super-Resolution Microscopy in depth with Eureka

Go past this page: query the whole super-resolution microscopy corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.